Health & Fitness:Medicine
SGLT2 inhibitors and GLP-1 receptor agonists now have well-established cardiovascular and renal benefits. What does this mean for their role in the management of type 2 diabetes? Justin Coleman chats with endocrinologist and clinical pharmacologist, Tilenka Thynne, about this and other updates to Therapeutic Guidelines Diabetes.
More Episodes
E35 – Treatment of irritable bowel syndrome
2018-10-15
2018-10-15
E32 – Travelling with medicines
2018-09-03
2018-09-03
E31 – Infantile colic
2018-08-20
2018-08-20
E30 – Fast-tracking of new drugs
2018-08-06
2018-08-06
E29 – Neuropathic pain
2018-07-19
2018-07-19
E28 – A RUM deal for unwanted medicines
2018-07-04
2018-07-04
E27 – Common eye infections
2018-06-20
2018-06-20
E25 – Antihistamines and allergy
2018-05-28
2018-05-28
E21 – The cost of asthma medicines
2018-04-04
2018-04-04
E20 – Prescribing for polymyalgia rheumatica
2018-03-19
2018-03-19
E17 – An update on the treatment of rosacea
2018-02-05
2018-02-05
E16 - Changes for codeine
2018-01-22
2018-01-22
Get this podcast on your
phone, FREE
